{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:41:18Z","timestamp":1792528878720,"version":"4.5.0"},"reference-count":160,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009634","name":"The Susan G Komen Breast Cancer Foundation Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018259","name":"Salk Institute for Biological Studies","doi-asserted-by":"publisher","award":["RRID: SCR_014846"],"award-info":[{"award-number":["RRID: SCR_014846"]}],"id":[{"id":"10.13039\/100018259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018259","name":"Salk Institute for Biological Studies","doi-asserted-by":"publisher","award":["RRID: SCR_014842"],"award-info":[{"award-number":["RRID: SCR_014842"]}],"id":[{"id":"10.13039\/100018259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004802","name":"California Breast Cancer Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004802","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012215","name":"Newman Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012215","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007850","name":"Waitt Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012639","name":"METAvivor Research and Support Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012639","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.celrep.2026.117957","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:54:01Z","timestamp":1789088041000},"page":"117957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["B cell responses to CD40 stimulation ignite anti-tumor immunity by activating CD8+ T cell cytotoxicity"],"prefix":"10.1016","volume":"45","author":[{"given":"Kendrick","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Quackenbush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Basbous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Lattanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsie","family":"Quansah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chynna","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sammy Weiser","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Boassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Ozbun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asona","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aatish","family":"Thennavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Wehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0332-5516","authenticated-orcid":false,"given":"Daniel","family":"Hollern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2026.117957_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41577-020-0275-8","article-title":"Dissecting the mechanisms of immune checkpoint therapy","volume":"20","author":"Sharma","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib2","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.ccell.2017.05.010","article-title":"SnapShot: immune checkpoint inhibitors","volume":"31","author":"Abril-Rodriguez","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.117957_bib3","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0952-7915(98)80228-8","article-title":"The role of CD4+ T cell responses in antitumor immunity","volume":"10","author":"Pardoll","year":"1998","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-065X.2008.00616.x","article-title":"Multiple roles for CD4+ T cells in anti-tumor immune responses","volume":"222","author":"Kennedy","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.celrep.2026.117957_bib5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s43018-023-00521-2","article-title":"CD4+ T cells in cancer","volume":"4","author":"Speiser","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.celrep.2026.117957_bib6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8+ T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.celrep.2026.117957_bib7","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1002\/jcp.27782","article-title":"CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review","volume":"234","author":"Farhood","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.celrep.2026.117957_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.intimp.2018.06.001","article-title":"Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors","volume":"62","author":"Hargadon","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.celrep.2026.117957_bib9","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1158\/1078-0432.CCR-21-0327","article-title":"FDA approval summary: pembrolizumab for the treatment of tumor mutational burden\u2013high solid tumors","volume":"27","author":"Marcus","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.117957_bib10","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1158\/1078-0432.CCR-22-1110","article-title":"FDA approval summary: pembrolizumab for neoadjuvant and adjuvant treatment of patients with high-risk early-stage triple-negative breast cancer","volume":"28","author":"Shah","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.117957_bib11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41416-018-0126-6","article-title":"Checkpoint blockade in the treatment of breast cancer: current status and future directions","volume":"119","author":"Wein","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.celrep.2026.117957_bib12","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.4049\/jimmunol.0903009","article-title":"B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice","volume":"184","author":"DiLillo","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib13","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.cell.2019.10.028","article-title":"B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer","volume":"179","author":"Hollern","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117957_bib14","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1016\/j.cell.2021.11.007","article-title":"Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses","volume":"184","author":"Cui","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117957_bib15","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.cell.2020.02.015","article-title":"Complement signals determine opposite effects of B cells in chemotherapy-induced immunity","volume":"180","author":"Lu","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117957_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abn5859","article-title":"Intratumoral immunotherapy relies on B and T cell collaboration","volume":"7","author":"Sagiv-Barfi","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib17","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1158\/1078-0432.CCR-19-3211","article-title":"B cells improve overall survival in HPV-associated squamous cell carcinomas and are activated by radiation and PD-1 blockade","volume":"26","author":"Kim","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.117957_bib18","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1158\/1078-0432.CCR-15-2762","article-title":"Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-cell responses, and superior prognosis in ovarian cancer","volume":"22","author":"Kroeger","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.117957_bib19","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.4049\/jimmunol.1001323","article-title":"CD20+ B cells: the other tumor-infiltrating lymphocytes","volume":"185","author":"Nelson","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib20","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.1158\/1078-0432.CCR-18-1481","article-title":"Prognostic significance of tumor-infiltrating B cells and plasma cells in human cancer","volume":"24","author":"Wouters","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.117957_bib21","series-title":"New Predictors for Immunotherapy Responses Sharpen Our View of the Tumour Microenvironment","author":"Bruno","year":"2020"},{"key":"10.1016\/j.celrep.2026.117957_bib22","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1038\/s41467-021-23355-x","article-title":"B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma","volume":"12","author":"Ruffin","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117957_bib23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3389\/fimmu.2016.00407","article-title":"Tertiary lymphoid structures in cancers: prognostic value, regulation, and manipulation for therapeutic intervention","volume":"7","author":"Saut\u00e8s-Fridman","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib24","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.ccell.2021.09.007","article-title":"B cells and cancer","volume":"39","author":"Engelhard","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.117957_bib25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41571-022-00619-z","article-title":"B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome","volume":"19","author":"Fridman","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.celrep.2026.117957_bib26","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1900635","article-title":"Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer","volume":"10","author":"J Gunderson","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.celrep.2026.117957_bib27","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117957_bib28","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","article-title":"B cells are associated with survival and immunotherapy response in sarcoma","volume":"577","author":"Petitprez","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117957_bib29","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117957_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clim.2017.10.002","article-title":"Non-progressing cancer patients have persistent B cell responses expressing shared antibody paratopes that target public tumor antigens","volume":"187","author":"DeFalco","year":"2018","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib31","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cell.2019.03.016","article-title":"B Cell Responses: Cell Interaction Dynamics and Decisions","volume":"177","author":"Cyster","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117957_bib32","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.immuni.2020.11.006","article-title":"Germinal Center and Extrafollicular B Cell Responses in Vaccination, Immunity, and Autoimmunity","volume":"53","author":"Elsner","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117957_bib33","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1016\/j.immuni.2025.08.007","article-title":"A roadmap for defining \u201cextrafollicular\u201d B cell responses","volume":"58","author":"Eisenbarth","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117957_bib34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/imr.12741","article-title":"Extrafollicular responses in humans and SLE","volume":"288","author":"Jenks","year":"2019","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.celrep.2026.117957_bib35","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1084\/jem.20111696","article-title":"A germinal center\u2013independent pathway generates unswitched memory B cells early in the primary response","volume":"209","author":"Taylor","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2026.117957_bib36","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/s43018-021-00232-6","article-title":"Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression","volume":"2","author":"Vanhersecke","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.celrep.2026.117957_bib37","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","article-title":"Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer","volume":"55","author":"Meylan","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117957_bib38","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/1744666X.2024.2380892","article-title":"Tumor-associated tertiary lymphoid structures in cancer: implications for immunotherapy","volume":"20","author":"Langouo Fontsa","year":"2024","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib39","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1164\/rccm.201309-1611OC","article-title":"Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer","volume":"189","author":"Germain","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.celrep.2026.117957_bib40","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.immuni.2023.08.009","article-title":"Tertiary lymphoid structures and B cells: An intratumoral immunity cycle","volume":"56","author":"Fridman","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117957_bib41","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev-immunol-020711-075032","article-title":"Germinal centers","volume":"30","author":"Victora","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib42","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1084\/jem.20102477","article-title":"A dynamic T cell\u2013limited checkpoint regulates affinity-dependent B cell entry into the germinal center","volume":"208","author":"Schwickert","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2026.117957_bib43","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1126\/science.1136736","article-title":"Imaging of germinal center selection events during affinity maturation","volume":"315","author":"Allen","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117957_bib44","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/s41423-023-01060-7","article-title":"Germinal center-dependent and-independent immune responses of tumor-infiltrating B cells in human cancers","volume":"20","author":"Playoust","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib45","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1038\/s41467-018-05772-7","article-title":"Memory B cells are reactivated in subcapsular proliferative foci of lymph nodes","volume":"9","author":"Moran","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117957_bib46","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1016\/j.cell.2024.06.038","article-title":"Pan-cancer single-cell dissection reveals phenotypically distinct B cell subtypes","volume":"187","author":"Yang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117957_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/science.adj4857","article-title":"A blueprint for tumor-infiltrating B cells across human cancers","volume":"384","author":"Ma","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117957_bib48","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1016\/j.cell.2024.07.037","article-title":"Memory B cell fitness and anergy has significant links to cancer lethality","volume":"187","author":"Hollern","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117957_bib49","doi-asserted-by":"crossref","unstructured":"Guo, Z., Nguyen, K., Claudio, N.M., Ziglari, T., Kan, B., Nambiar, D., Unsworth, J., Schuster, V., Quackenbush, M., and Ozbun, T. Sentinel Node B Cells Drive Epitope Spreading and Anti-tumor T Cell Immunity by Recognition and Presentation of Extracellular Vesicle-Linked Antigens. https:\/\/doi.org\/10.2139\/ssrn.4912248 .","DOI":"10.2139\/ssrn.4912248"},{"key":"10.1016\/j.celrep.2026.117957_bib50","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1084\/jem.20060087","article-title":"Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation","volume":"203","author":"Paus","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2026.117957_bib51","doi-asserted-by":"crossref","first-page":"7932","DOI":"10.1073\/pnas.1018571108","article-title":"Facultative role for T cells in extrafollicular Toll-like receptor-dependent autoreactive B-cell responses in vivo","volume":"108","author":"Sweet","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117957_bib52","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.coi.2007.04.009","article-title":"Affinity of antigen encounter and other early B-cell signals determine B-cell fate","volume":"19","author":"Benson","year":"2007","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib53","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1084\/jem.20011550","article-title":"Very low affinity B cells form germinal centers, become memory B cells, and participate in secondary immune responses when higher affinity competition is reduced","volume":"195","author":"Dal Porto","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2026.117957_bib54","doi-asserted-by":"crossref","first-page":"7723","DOI":"10.4049\/jimmunol.177.11.7723","article-title":"Imprinting the fate of antigen-reactive B cells through the affinity of the B cell receptor","volume":"177","author":"O\u2019Connor","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib55","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1158\/2159-8290.CD-15-0843","article-title":"IL35-Producing B Cells Promote the Development of Pancreatic Neoplasia","volume":"6","author":"Pylayeva-Gupta","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2026.117957_bib56","doi-asserted-by":"crossref","first-page":"27740","DOI":"10.18632\/oncotarget.7720","article-title":"CD40-activated B cells induce anti-tumor immunity in vivo","volume":"8","author":"Wennhold","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.celrep.2026.117957_bib57","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev-med-062518-045435","article-title":"CD40 Agonist Antibodies in Cancer Immunotherapy","volume":"71","author":"Vonderheide","year":"2020","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.celrep.2026.117957_bib58","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1158\/1078-0432.CCR-23-0475","article-title":"A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Confirmed Disease Progression on Anti-PD-1 Therapy","volume":"30","author":"Weiss","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.117957_bib59","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s00262-020-02814-2","article-title":"APX005M, a CD40 agonist antibody with unique epitope specificity and Fc receptor binding profile for optimal therapeutic application","volume":"70","author":"Filbert","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.celrep.2026.117957_bib60","series-title":"Phase 1 Pilot Study with Dose Expansion of Chemotherapy in Combination with CD40 Agonist and Flt3 Ligand in Metastatic Triple-Negative Breast Cancer","author":"Reddy","year":"2022"},{"key":"10.1016\/j.celrep.2026.117957_bib61","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13045-025-01732-z","article-title":"The role of neoantigens and tumor mutational burden in cancer immunotherapy: advances, mechanisms, and perspectives","volume":"18","author":"Sun","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.celrep.2026.117957_bib62","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.3389\/fimmu.2019.01856","article-title":"Mutation-derived neoantigens for cancer immunotherapy","volume":"10","author":"Castle","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib63","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117957_bib64","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10549-018-5061-y","article-title":"A mouse model featuring tissue-specific deletion of p53 and Brca1 gives rise to mammary tumors with genomic and transcriptomic similarities to human basal-like breast cancer","volume":"174","author":"Hollern","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.celrep.2026.117957_bib65","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/gb-2007-8-5-r76","article-title":"Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors","volume":"8","author":"Herschkowitz","year":"2007","journal-title":"Genome Biol."},{"key":"10.1016\/j.celrep.2026.117957_bib66","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1073\/pnas.1018862108","article-title":"Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells","volume":"109","author":"Herschkowitz","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117957_bib67","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1200\/JCO.21.01506","article-title":"CALGB 40603 (Alliance): long-term outcomes and genomic correlates of response and survival after neoadjuvant chemotherapy with or without carboplatin and bevacizumab in triple-negative breast cancer","volume":"40","author":"Shepherd","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.celrep.2026.117957_bib68","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1349-7006.2012.02231.x","article-title":"GSTP 1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer","volume":"103","author":"Miyake","year":"2012","journal-title":"Cancer Sci."},{"key":"10.1016\/j.celrep.2026.117957_bib69","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1158\/1078-0432.CCR-17-1912","article-title":"Pathological response in a triple-negative breast cancer cohort treated with neoadjuvant carboplatin and docetaxel according to Lehmann's refined classification","volume":"24","author":"Echavarria","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.117957_bib137","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1200\/JCO.2014.57.0572","volume":"33","author":"Sikov","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.celrep.2026.117957_bib70","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1084\/jem.183.1.77","article-title":"CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype","volume":"183","author":"Galibert","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2026.117957_bib71","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.4049\/jimmunol.168.11.5491","article-title":"CD40 ligation conditions dendritic cell antigen-presenting function through sustained activation of NF-\u03baB","volume":"168","author":"O\u2019Sullivan","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60865-2","article-title":"CD40-CD40 ligand: a multifunctional receptor-ligand pair","volume":"61","author":"Kooten","year":"1996","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib73","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1126\/science.1198443","article-title":"CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans","volume":"331","author":"Beatty","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117957_bib74","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1158\/0008-5472.CAN-13-3461","article-title":"Immune-based antitumor effects of BRAF inhibitors rely on signaling by CD40L and IFNgamma","volume":"74","author":"Ho","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2026.117957_bib75","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nri2644","article-title":"New insights into the differentiation and function of T follicular helper cells","volume":"9","author":"King","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib76","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/IR:24:2:097","article-title":"Signaling by CD40 and its mimics in B cell activation","volume":"24","author":"Bishop","year":"2001","journal-title":"Immunol. Res."},{"key":"10.1016\/j.celrep.2026.117957_bib77","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1084\/jem.178.3.1097","article-title":"B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells","volume":"178","author":"Nonoyama","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2026.117957_bib78","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0952-7915(97)80078-7","article-title":"Functions of CD40 on B cells, dendritic cells and other cells","volume":"9","author":"van Kooten","year":"1997","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib79","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","article-title":"Molecular mechanism and function of CD40\/CD40L engagement in the immune system","volume":"229","author":"Elgueta","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.celrep.2026.117957_bib80","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.44245","article-title":"The quantity of CD40 signaling determines the differentiation of B cells into functionally distinct memory cell subsets","volume":"8","author":"Koike","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.celrep.2026.117957_bib81","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1126\/science.1198443","article-title":"CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans","volume":"331","author":"Beatty","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117957_bib88","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117957_bib82","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41590-021-01078-x","article-title":"Surface phenotypes of naive and memory B cells in mouse and human tissues","volume":"23","author":"Weisel","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib84","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.celrep.2019.04.019","article-title":"FCRL5+ memory B cells exhibit robust recall responses","volume":"27","author":"Kim","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2026.117957_bib83","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.immuni.2016.06.014","article-title":"Somatically hypermutated plasmodium-specific IgM+ memory B cells are rapid, plastic, early responders upon malaria rechallenge","volume":"45","author":"Krishnamurty","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117957_bib85","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/intimm\/dxaa053","article-title":"Fc receptor-like 4 and 5 define human atypical memory B cells","volume":"32","author":"Li","year":"2020","journal-title":"Int. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib86","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41590-018-0177-0","article-title":"IL-9 receptor signaling in memory B cells regulates humoral recall responses","volume":"19","author":"Takatsuka","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib87","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/ni.3788","article-title":"Germinal-center development of memory B cells driven by IL-9 from follicular helper T cells","volume":"18","author":"Wang","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib89","article-title":"CD226 identifies functional CD8+ T cells in the tumor microenvironment and predicts a better outcome for human gastric cancer","volume":"14","author":"Huang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib90","doi-asserted-by":"crossref","first-page":"5453","DOI":"10.4049\/jimmunol.0803090","article-title":"Expression of CD226 antagonizes apoptotic cell death in murine thymocytes","volume":"182","author":"Fang","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib91","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/ni.2494","article-title":"IL-7 signaling must be intermittent, not continuous, during CD8+ T cell homeostasis to promote cell survival instead of cell death","volume":"14","author":"Kimura","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib92","doi-asserted-by":"crossref","first-page":"5315","DOI":"10.4049\/jimmunol.157.12.5315","article-title":"Impaired survival and proliferation in IL-7 receptor-deficient peripheral T cells","volume":"157","author":"Maraskovsky","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib93","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1023\/B:JOCI.0000018060.36183.bb","article-title":"Increased CD8+ T cell apoptosis in scleroderma is associated with low levels of NF-\u03baB","volume":"24","author":"Kessel","year":"2004","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib94","first-page":"940s","article-title":"Tumor-induced sensitivity to apoptosis in T cells from patients with renal cell carcinoma: role of nuclear factor-\u03baB suppression","volume":"7","author":"Finke","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.117957_bib95","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nri911","article-title":"Functional significance of the perforin\/granzyme cell death pathway","volume":"2","author":"Trapani","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib96","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ng0506-500","article-title":"GenePattern 2.0","volume":"38","author":"Reich","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2026.117957_bib97","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0002-9440(10)64126-0","article-title":"Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection","volume":"158","author":"Agostini","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.celrep.2026.117957_bib98","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/sj.bjc.6606056","article-title":"CXCL9 induces chemotaxis, chemorepulsion and endothelial barrier disruption through CXCR3-mediated activation of melanoma cells","volume":"104","author":"Amatschek","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.celrep.2026.117957_bib99","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/jid.2011.371","article-title":"CXCL16 and CXCR6 are upregulated in psoriasis and mediate cutaneous recruitment of human CD8+ T cells","volume":"132","author":"G\u00fcnther","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.celrep.2026.117957_bib100","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abq6509","article-title":"CXCL9 and CXCL10 bring the heat to tumors","volume":"7","author":"Reschke","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib101","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/art.21004","article-title":"Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid joints","volume":"52","author":"Van Der Voort","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.celrep.2026.117957_bib102","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41596-024-01045-4","article-title":"CellChat for systematic analysis of cell-cell communication from single-cell and spatially resolved transcriptomics","volume":"20","author":"Jin","year":"2025","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.celrep.2026.117957_bib103","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/ijms17030320","article-title":"CD86+\/CD206+, diametrically polarized tumor-associated macrophages, predict hepatocellular carcinoma patient prognosis","volume":"17","author":"Dong","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.celrep.2026.117957_bib104","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.3390\/cancers13143422","article-title":"The prognostic value of CD206 in solid malignancies: a systematic review and meta-analysis","volume":"13","author":"Debacker","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.celrep.2026.117957_bib105","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1189\/jlb.4A0415-152R","article-title":"Hepatic CD206-positive macrophages express amphiregulin to promote the immunosuppressive activity of regulatory T cells in HBV infection","volume":"98","author":"Dai","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.celrep.2026.117957_bib106","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","article-title":"Macrophage-derived CXCL9 and CXCL10 are required for antitumor immune responses following immune checkpoint blockade","volume":"26","author":"House","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.117957_bib107","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.immuni.2012.11.012","article-title":"Peripheral prepositioning and local CXCL9 chemokine-mediated guidance orchestrate rapid memory CD8+ T cell responses in the lymph node","volume":"38","author":"Kastenm\u00fcller","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117957_bib108","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002045","article-title":"CXCL9-expressing tumor-associated macrophages: new players in the fight against cancer","volume":"9","author":"Marcovecchio","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.celrep.2026.117957_bib109","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4049\/jimmunol.154.1.97","article-title":"CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL","volume":"154","author":"Lanier","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib138","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.849","article-title":"Basic image analysis and manipulation in ImageJ\/Fiji","volume":"3","author":"Stossi","year":"2023","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.celrep.2026.117957_bib110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fimmu.2011.00072","article-title":"Initiation of TCR phosphorylation and signal transduction","volume":"2","author":"Gascoigne","year":"2011","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib111","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/eji.200738026","article-title":"Redundant role for Zap70 in B cell development and activation","volume":"38","author":"Fallah-Arani","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib112","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/eji.200526355","article-title":"B lymphocytes in humans express ZAP-70 when activated in vivo","volume":"36","author":"Cutrona","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib113","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/sj.leu.2403726","article-title":"ZAP-70 is expressed by a subset of normal human B-lymphocytes displaying an activated phenotype","volume":"19","author":"Nolz","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.celrep.2026.117957_bib114","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/sj.leu.2404138","article-title":"ZAP-70 is expressed by normal and malignant human B-cell subsets of different maturational stage","volume":"20","author":"Scielzo","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.celrep.2026.117957_bib115","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1084\/jem.191.2.335","article-title":"Critical role for CD8 in T cell receptor binding and activation by peptide\/major histocompatibility complex multimers","volume":"191","author":"Daniels","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2026.117957_bib116","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1158\/1078-0432.CCR-23-0475","article-title":"A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Confirmed Disease Progression on Anti-PD-1 Therapy","volume":"30","author":"Weiss","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.117957_bib117","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1084\/jem.180.1.141","article-title":"Memory B cell development but not germinal center formation is impaired by in vivo blockade of CD40-CD40 ligand interaction","volume":"180","author":"Gray","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2026.117957_bib118","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1158\/1078-0432.CCR-12-0234","article-title":"CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer","volume":"18","author":"Nielsen","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.117957_bib119","doi-asserted-by":"crossref","DOI":"10.1126\/science.adj4857","article-title":"A blueprint for tumor-infiltrating B cells across human cancers","volume":"384","author":"Ma","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117957_bib120","doi-asserted-by":"crossref","DOI":"10.1111\/imr.70066","article-title":"Extrafollicular B Cell Responses\u2014Is One Tent Big Enough?","volume":"336","author":"Baumgarth","year":"2025","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.celrep.2026.117957_bib121","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.ccell.2025.07.013","article-title":"Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancer","volume":"43","author":"Osorio","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.117957_bib122","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1038\/s41467-021-24347-7","article-title":"Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma","volume":"12","author":"van Hooren","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117957_bib123","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ni.1723","article-title":"T cell antigen receptor signaling and immunological synapse stability require myosin IIA","volume":"10","author":"Ilani","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib124","doi-asserted-by":"crossref","first-page":"9978","DOI":"10.1128\/JVI.01326-08","article-title":"CD20, CD3, and CD40 ligand microclusters segregate three-dimensionally in vivo at B-cell-T-cell immunological synapses after viral immunity in primate brain","volume":"82","author":"Barcia","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2026.117957_bib125","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s40425-019-0726-6","article-title":"Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8+ T cells","volume":"7","author":"Hlad\u00edkov\u00e1","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.celrep.2026.117957_bib126","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56441-8","article-title":"The prognostic importance of CD20+ B lymphocytes in colorectal cancer and the relation to other immune cell subsets","volume":"9","author":"Edin","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2026.117957_bib127","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1182\/blood-2003-07-2379","article-title":"RNA-transfected CD40-activated B cells induce functional T-cell responses against viral and tumor antigen targets: implications for pediatric immunotherapy","volume":"103","author":"Coughlin","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2026.117957_bib128","doi-asserted-by":"crossref","first-page":"67901","DOI":"10.18632\/oncotarget.12178","article-title":"B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccines","volume":"7","author":"Colluru","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.celrep.2026.117957_bib129","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1016\/j.cell.2021.11.007","article-title":"Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses","volume":"184","author":"Cui","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117957_bib130","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.ccell.2025.07.001","article-title":"Adoptively transferred Th17 cells cooperate with host B cells to achieve durable tumor immunity","volume":"43","author":"Cole","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.117957_bib131","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.celrep.2016.05.058","article-title":"CD40 stimulation obviates innate sensors and drives T cell immunity in cancer","volume":"15","author":"Byrne","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2026.117957_bib132","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adp3978","article-title":"Combined Flt3L and CD40 agonism restores dendritic cell\u2013driven T cell immunity in pancreatic cancer","volume":"10","author":"Hogg","year":"2025","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib133","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1490854","article-title":"Tumor mutational burden is a determinant of immune-mediated survival in breast cancer","volume":"7","author":"Thomas","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.celrep.2026.117957_bib134","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1158\/2159-8290.CD-20-0522","article-title":"Tumor mutational burden as a predictive biomarker in solid tumors","volume":"10","author":"Sha","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2026.117957_bib135","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1490854","article-title":"Tumor mutational burden is a determinant of immune-mediated survival in breast cancer","volume":"7","author":"Thomas","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.celrep.2026.117957_bib136","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003091","article-title":"Tumor mutational burden predicts the efficacy of pembrolizumab monotherapy: a pan-tumor retrospective analysis of participants with advanced solid tumors","volume":"10","author":"Cristescu","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.celrep.2026.117957_bib157","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nbt.3192","article-title":"Spatial reconstruction of single-cell gene expression data","volume":"33","author":"Satija","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celrep.2026.117957_bib151","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celrep.2026.117957_bib145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2026.117957_bib158","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2026.117957_bib148","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/bioinformatics\/bth078","article-title":"Open source clustering software","volume":"20","author":"de Hoon","year":"2004","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2026.117957_bib159","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2026.117957_bib160","series-title":"Package \u2018sigclust\u2019. Statistical Significance ofClustering","author":"Huang","year":"2015"},{"key":"10.1016\/j.celrep.2026.117957_bib141","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: Open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2026.117957_bib139","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.3389\/fimmu.2019.02458","article-title":"Challenges and opportunities for consistent classification of human B cell and plasma cell populations","volume":"10","author":"Sanz","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib140","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4049\/jimmunol.1401553","article-title":"CCR6-dependent positioning of memory B cells is essential for their ability to mount a recall response to antigen","volume":"194","author":"Elgueta","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2026.117957_bib142","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.3390\/cancers14122916","article-title":"StarDist image segmentation improves circulating tumor cell detection","volume":"14","author":"Stevens","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.celrep.2026.117957_bib143","series-title":"Cellular Imaging: Electron Tomography and Related Techniques","first-page":"149","article-title":"Conjugate immunofluorescence\u2014SEM array tomography for studying mammalian synapses and axons","author":"Micheva","year":"2017"},{"key":"10.1016\/j.celrep.2026.117957_bib144","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035172","article-title":"Serial section scanning electron microscopy (S3EM) on silicon wafers for ultra-structural volume imaging of cells and tissues","volume":"7","author":"Horstmann","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2026.117957_bib146","article-title":"Salmon: accurate, versatile and ultrafast quantification from RNA-seq data using lightweight-alignment","author":"Patro","year":"2015","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2026.117957_bib147","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1471-2105-11-94","article-title":"Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments","volume":"11","author":"Bullard","year":"2010","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.celrep.2026.117957_bib149","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2164-10-22","article-title":"BioMart\u2013biological queries made easy","volume":"10","author":"Smedley","year":"2009","journal-title":"BMC Genomics"},{"key":"10.1016\/j.celrep.2026.117957_bib150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1755-8794-4-3","article-title":"Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures","volume":"4","author":"Fan","year":"2011","journal-title":"BMC Med. Genomics"},{"key":"10.1016\/j.celrep.2026.117957_bib152","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1016\/j.cell.2024.06.038","article-title":"Pan-cancer single-cell dissection reveals phenotypically distinct B cell subtypes","volume":"187","author":"Yang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117957_bib153","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/s41592-023-02014-7","article-title":"Extending support for mouse data in the Molecular Signatures Database (MSigDB)","volume":"20","author":"Castanza","year":"2023","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2026.117957_bib154","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.celrep.2026.117957_bib155","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. Ser. B: Stat. Methodol."},{"key":"10.1016\/j.celrep.2026.117957_bib156","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2307\/3001968","article-title":"Individual comparisons by ranking methods","volume":"1","author":"Wilcoxon","year":"1945","journal-title":"Biom. Bull."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726010351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726010351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:36:18Z","timestamp":1792528578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124726010351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":160,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2211124726010351"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117957","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B cell responses to CD40 stimulation ignite anti-tumor immunity by activating CD8+ T cell cytotoxicity","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117957","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117957"}}